Necrotizing external otitis on a Crohn's disease patient treated with infliximab
نویسندگان
چکیده
منابع مشابه
Necrotizing external otitis on a Crohn's disease patient treated with infliximab.
This letter is about a 27 years old female with the diagnosis of Crohn's disease since July 2004, involving the duodenum, ileum and right colon. She was first treated with Mesalamine (1 g 3 id for 20 d, suspended because of the absence of efficacy), Prednisolone (four episode treatment, tapered), Azathioprine (since July 2004, up to 2.5 mg/Kg/d). She had four previous admissions at our hospital...
متن کاملSevere Parkinson's disease in rheumatoid arthritis patient treated with infliximab.
SIR, Infections are the most common adverse events associated with the use of tumour necrosis factor-a (TNF-a) inhibitors in rheumatoid arthritis (RA), and neurological complications are far less common. Nevertheless, the review of the Adverse Events Reporting System of the Food and Drug Administration (FDA) revealed a number of neurological events suggestive of demyelination that occurred duri...
متن کاملA Case of Osteonecrosis of the Jaw in a Patient with Crohn’s Disease Treated with Infliximab
Objective: Unusual clinical course Background: Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug reaction, occurring in patients undergoing treatments with antiresorptive or antiangiogenic agents, such as bisphosphonates, denosumab, or bevacizumab, for different oncologic and non-oncologic diseases. The aim of this study was to report a case of MRONJ in a patient taki...
متن کاملEffect of infliximab top-down therapy on weight gain in pediatric Crohns disease.
This retrospective-medical-record review was conducted to evaluate effect of infliximab therapy, particularly with a top-down strategy, on the nutritional parameters of children with Crohns disease (CD). 42 patients who were diagnosed with Crohns disease at the Pediatric Gastroenterology center of a tertiary care teaching hospital and achieved remission at two months and one year after beginnin...
متن کاملExacerbation of atopic dermatitis in a patient treated with infliximab.
in the literature on the use of imiquimod in EMPD, found complete remission of the disease in 21 of the 27 reported cases (78%). The factors that influence the success or failure of imiquimod therapy in this setting have not yet been clearly established. Factors that might explain the variability of response to treatment include the size of the lesion, its variable thickness in different areas,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Crohn's and Colitis
سال: 2010
ISSN: 1873-9946
DOI: 10.1016/j.crohns.2009.10.003